Showing results (51-60 of 166) with videos related to
Sort By:
Pageof 17
Cell Reports|April 8, 2014
Linkage of DNA methylation quantitative trait loci to human cancer riskHolger Heyn, Sergi Sayols, Catia Moutinho, et al.Journal for Immunotherapy of Cancer|February 26, 2021
Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classificationAnia Alay, David Cordero, Sara Hijazo-Pechero, et al.Clinical Lung Cancer|January 11, 2018
Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib ResultsMartin Reck, Edward B Garon, Luis Paz-Ares, et al.Drug Safety|December 20, 2021
RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and ManageabilityErnest Nadal, Hidehito Horinouchi, Jin-Yuan Shih, et al.Clinical Lung Cancer|July 13, 2024
MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLCMartin Reck, Ernest Nadal, Nicolas Girard, et al.BMC Cancer|April 5, 2020
Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancerMercedes Delgado-García, Birgit Weynand, Lourdes Gómez-Izquierdo, et al.British Journal of Cancer|December 26, 2022
3D collagen migration patterns reveal a SMAD3-dependent and TGF-β1-independent mechanism of recruitment for tumour-associated fibroblasts in lung adenocarcinomaYago Juste-Lanas, Natalia Díaz-Valdivia, Alejandro Llorente, et al.BMC Cancer|February 23, 2019
Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapyMilana Bergamino, Antonio J Rullan, Maria Saigí, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 31, 2010
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancerRuben Pio, Javier Garcia, Leticia Corrales, et al.Nature Medicine|May 30, 2018
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivoSara Mainardi, Antonio Mulero-Sánchez, Anirudh Prahallad, et al.Pageof 17